| Wissenschaftl. Titel | A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab Compared With Chemotherapy in Patients With Treatment Naïve Advanced or Recurrent (Stage IIIb Not Amenable for Multimodality Treatment) or Metastatic (Stage IV) Non-Small Cell Lung Cancer Who Are Deemed Unsuitable for Platinum-Containing Therapy |
| Erkrankung |
Lunge:
Lungenkrebs:
Nicht kleinzelliges Lungenkarzinom (NSCLC) - Erstlinie
|
| Molekularer Marker |
EGFR wt |
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 20.05.2019 Student Studienregister
geändert 12.09.2022 Student Studienregister